Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1515 Articles

Chris Lange | Oct 29, 2019 at 10:20 AM EDT

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Shares of Merck and Pfizer both got boosts after they reported their most recent quarterly results before the opening bell…

Chris Lange | Oct 28, 2019 at 1:25 PM EDT

Merck and Pfizer Earnings: What to Expect

Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one…

Chris Lange | Oct 27, 2019 at 6:50 AM EDT

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Oct 25, 2019 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Microsoft, Intel and Pfizer above all other Dow stocks.

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Oct 10, 2019 at 7:05 AM EDT

5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Lee Jackson | Sep 30, 2019 at 7:30 AM EDT

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid…

Chris Lange | Sep 27, 2019 at 9:55 AM EDT

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Sep 25, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Sep 12, 2019 at 6:50 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

1 … 27 28 29 30 31 … 101

Pfizer : PFE

All Pfizer Articles

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Merck and Pfizer Earnings: What to Expect

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Pfizer : PFE

All Pfizer Articles

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Merck and Pfizer Earnings: What to Expect

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Featured Reads

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead